New York, New York (PRWEB) February 05, 2012
Bernstein Liebhard LLP reports that on January 31, 2012, Democratic Representative Edward Markey of Massachusetts introduced a bill (HR3847) that would block medical devices from utilizing the 510(k) process in order to receive market approval by the U.S. Food and Drug Administration (“FDA”) if approval is predicated on the similarity of a previously recalled device.* If passed, the legislation would close a loophole that lets devices like transvaginal mesh receive market clearance if they are substantially similar to a product that has been previously pulled from the market. According to Bloomberg News, “[v]aginal implants spurred a Food and Drug Administration alert last year amid patient complaints of pain and internal injuries. The devices were cleared by the agency’s 510(k) system, which allowed them to be sold without human testing once the FDA rules they are similar to existing products.” In support of the new legislation, House Democrats cited injuries stemming from pelvic mesh implants, which are manufactured by medical device powerhouses including Johnson & Johnson subsidiary, Ethicon, and C.R. Bard. The bill would give the FDA authority to reject medical devices if their predecessors were subject to a recall or in the process of being recalled. It would also require medical device manufacturers to explain why their products are different from earlier versions.
Bill Follows Calls For Congressional Hearings To Examine Safety Of Medical Devices
Previously, on January 20, 2012, Representative Henry Waxman of California led House Democrats from the Energy and Commerce Committee in writing a letter to several chairmen, requesting that the Committee hold hearings to review the safety of medical devices implanted into patients.** In support of their petition, the congressmen cited problems associated with medical devices, such as vaginal mesh implants, which have caused serious injuries to patients. According to the congressmen, these harms demonstrate the need for regulatory reform. In order for the bill to become law, HR3847 would need to be passed in the Republican-dominated House and Democratic-controlled Senate before being signed by President Obama.
The lawyers at Bernstein Liebhard are actively filing cases on behalf of individuals allegedly injured by vaginal mesh implants. For more information about filing a vaginal mesh lawsuit, contact an attorney at Bernstein Liebhard LLP at (877) 779-1414 or at info(at)consumerinjurylawyers(dot)com.
**January 20, 2012 Letter to Chairmen of Committee on Energy and Commerce
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP